Hans J. Prochaska

3.5k total citations · 1 hit paper
31 papers, 2.7k citations indexed

About

Hans J. Prochaska is a scholar working on Molecular Biology, Organic Chemistry and Toxicology. According to data from OpenAlex, Hans J. Prochaska has authored 31 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 9 papers in Organic Chemistry and 9 papers in Toxicology. Recurrent topics in Hans J. Prochaska's work include Genomics, phytochemicals, and oxidative stress (14 papers), Bioactive Compounds and Antitumor Agents (9 papers) and Glutathione Transferases and Polymorphisms (8 papers). Hans J. Prochaska is often cited by papers focused on Genomics, phytochemicals, and oxidative stress (14 papers), Bioactive Compounds and Antitumor Agents (9 papers) and Glutathione Transferases and Polymorphisms (8 papers). Hans J. Prochaska collaborates with scholars based in United States and Germany. Hans J. Prochaska's co-authors include Paul Talalay, Annette B. Santamaria, Mary Jane Long, Penny Baron, Bruce Polsky, Tory Prestera, Helmut Sies, Yi‐Ching Yeh, Howard Bregman and J.A. Potenza and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Hans J. Prochaska

31 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of a common chemical signal regulating the induction of enzymes that protect against chemical carcinogenesis.

1988 509 citations Paul Talalay, Mary Jane Long et al. profile →

Peers

Hans J. Prochaska

TOXIC

PHARM

C. Clifford Conaway United States

Jih-Pyang Wang Taiwan

Chun‐Nan Lin Taiwan

Tory Prestera United States

Teruo Mukainaka Japan

Ann M. Benson United States

Ushio Sankawa Japan

Lucio Merlini Italy

Koichi Takeya Japan

Akio Iwashima Japan

C. Clifford Conaway United States

Hans J. Prochaska

1.9k ×0.9

540 ×0.8

135 ×0.3

TOXIC

432 ×1.3

153 ×0.5

PHARM

Citations per year, relative to Hans J. Prochaska Hans J. Prochaska (= 1×) peers C. Clifford Conaway

Countries citing papers authored by Hans J. Prochaska

Since Specialization

Citations

This map shows the geographic impact of Hans J. Prochaska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans J. Prochaska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans J. Prochaska more than expected).

Fields of papers citing papers by Hans J. Prochaska

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans J. Prochaska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans J. Prochaska. The network helps show where Hans J. Prochaska may publish in the future.

Co-authorship network of co-authors of Hans J. Prochaska

This figure shows the co-authorship network connecting the top 25 collaborators of Hans J. Prochaska. A scholar is included among the top collaborators of Hans J. Prochaska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans J. Prochaska. Hans J. Prochaska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hennig, Jürgen, et al.. (1998). Personality Correlates of +/- Pindolol Induced Decreases in Prolactin. Pharmacopsychiatry. 31(1). 19–24. 7 indexed citations

Prochaska, Hans J., et al.. (1996). Inhibition of Human Immunodeficiency Virus Type 1 Long Terminal Repeat-Driven Transcription by anin VivoMetabolite of Oltipraz: Implications for Antiretroviral Therapy. Biochemical and Biophysical Research Communications. 221(3). 548–553. 17 indexed citations

Dong, Jiahui, et al.. (1996). Elevations of Hepatic Quinone Reductase, Glutathione, and α- and μ-Class GlutathioneS-Transferase Isoforms in Mice with Chronic Hepatitis: A Compensatory Response to Injury. Archives of Biochemistry and Biophysics. 331(1). 104–116. 13 indexed citations

Bornmann, William G., et al.. (1995). Inactivation of Human Immunodeficiency Virus Type 1 Reverse Transcriptase by Oltipraz: Evidence for the Formation of a Stable Adduct. Archives of Biochemistry and Biophysics. 324(1). 143–152. 3 indexed citations

Prochaska, Hans J., et al.. (1995). Fluorometric Measurement of Reverse Transcriptase Activity with 4′,6-Diamidino-2-phenylindole. Analytical Biochemistry. 225(1). 54–59. 3 indexed citations

Prochaska, Hans J., et al.. (1995). Oltipraz, a novel inhibitor of human immunodeficiency virus type 1 (HIV-1) replication. Journal of Cellular Biochemistry. 59(S22). 117–125. 14 indexed citations

Prochaska, Hans J., W. G. BORNMANN, Penny Baron, & Bruce Polsky. (1995). Inhibition of human immunodeficiency virus type 1 replication by 7-methyl-6,8-bis(methylthio)pyrrolo[1,2-a]pyrazine, an in vivo metabolite of oltipraz.. Molecular Pharmacology. 48(1). 15–20. 7 indexed citations

Prochaska, Hans J., et al.. (1994). Elevation of glutathione levels by phase II enzyme inducers: lack of inhibition of human immunodeficiency virus type 1 replication in chronically infected monocytoid cells.. Molecular Pharmacology. 45(5). 916–921. 13 indexed citations

Chen, Shiuan, P. A. Martino, P S Deng, et al.. (1994). Mouse liver NAD(P)H:quinone acceptor oxidoreductase: Protein sequence analysis by tandem mass spectrometry, cDNA cloning, expression inEscherichia coli, and enzyme activity analysis. Protein Science. 3(8). 1296–1304. 31 indexed citations

10.

Prochaska, Hans J.. (1994). Screening strategies for the detection of anticarcinogenic enzyme inducers. The Journal of Nutritional Biochemistry. 5(7). 360–368. 19 indexed citations

11.

Prochaska, Hans J., et al.. (1993). Elevation of serum Phase II enzymes by anticarcinogenic enzyme inducers: markers for a chemoprotected state?. Carcinogenesis. 14(12). 2441–2445. 57 indexed citations

12.

Kensler, Thomas W., Nancy E. Davidson, John D. Groopman, et al.. (1993). Chemoprotection by Inducers of Electrophile Detoxication Enzymes. PubMed. 61. 127–136. 17 indexed citations

13.

Prestera, Tory, Hans J. Prochaska, & Paul Talalay. (1992). Inhibition of NAD(P)H:(quinone-acceptor) oxidoreductase by Cibacron Blue and related anthraquinone dyes: a structure-activity study. Biochemistry. 31(3). 824–833. 48 indexed citations

14.

Gordon, Gary, et al.. (1991). Induction of NAD(P)H:quinone reductase in human peripheral blood lymphocytes. Carcinogenesis. 12(12). 2393–2396. 25 indexed citations

15.

Prochaska, Hans J.. (1988). Purification and crystallization of rat liver NAD(P)H:(quinone-acceptor) oxidoreductase by cibacron blue affinity chromatography: Identification of a new and potent inhibitor. Archives of Biochemistry and Biophysics. 267(2). 529–538. 62 indexed citations

16.

Prochaska, Hans J. & Annette B. Santamaria. (1988). Direct measurement of NAD(P)H:quinone reductase from cells cultured in microtiter wells: A screening assay for anticarcinogenic enzyme inducers. Analytical Biochemistry. 169(2). 328–336. 441 indexed citations

17.

Prochaska, Hans J., Paul Talalay, & Helmut Sies. (1987). Direct protective effect of NAD(P)H:quinone reductase against menadione-induced chemiluminescence of postmitochondrial fractions of mouse liver.. Journal of Biological Chemistry. 262(5). 1931–1934. 47 indexed citations

18.

Amzel, L. Mario, Stephen H. Bryant, Hans J. Prochaska, & Paul Talalay. (1986). Preliminary crystallographic X-ray data for an NAD(P)H:quinone reductase from mouse liver.. Journal of Biological Chemistry. 261(3). 1379–1379. 16 indexed citations

19.

Long, Mary Jane, Hans J. Prochaska, & Paul Talalay. (1985). Tissue-specific induction patterns of cancer-protective enzymes in mice by tert-butyl-4-hydroxyanisole and related substituted phenols.. PubMed. 45(2). 546–51. 64 indexed citations

20.

Prochaska, Hans J., William F. Schwindinger, M. Schwartz, et al.. (1981). ChemInform Abstract: CHARACTERIZATION OF APICAL COPPER(II)‐THIOETHER BONDING. STRUCTURE AND ELECTRONIC SPECTRA OF BIS(2,2‐BIS(5‐PHENYL‐2‐IMIDAZOLYL)PROPANE)COPPER(II) DIPERCHLORATE AND BIS(1,3‐BIS(5‐PHENYL‐2‐IMIDAZOLYL)‐2‐THIAPROPANE)COPPER(II) DIPERCHLORATE. Chemischer Informationsdienst. 12(39). 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact